Enrolling in clinical trials

Clinical trials advance treatments and care so people with type 1 diabetes can live fuller, healthier lives.

Doctor speaks to patient about clinical trials

Clinical trials

Critical to making type 1 diabetes a condition of the past

For a treatment, drug, or device to make it into the hands of people with type 1 diabetes (T1D), it must first complete a vital step—a clinical trial. 

Currently, there are over 300 clinical trials underway to prevent, cure, and treat T1D and its complications. Enrolling in these clinical trials as quickly as possible is mission critical. 

We’re here to make it as easy as possible for every member of this incredible community to learn more about type 1 diabetes clinical trials and consider participation. 

Learn more about clinical trials

Despite how critical clinical trials are to finding therapies to cure, prevent, and treat T1D, many are delayed due to slow enrollment, adding cost and prolonging the results. Participating in a clinical trial is a great way to contribute to a future without T1D!

Teens that learned more about type 1 diabetes clinical trials

Visit our partners at Antidote to match with clinical trials you might be eligible for—all in under a minute.


Our Clinical Trial Education Volunteers (CTEVs) are highly trained to answer questions you may have or connect you to local clinical trial coordinators.


Sign up for our monthly research newsletter, The Pipeline, for the latest in type 1 diabetes science and clinical research.

We want every member of the diverse T1D community to be aware of clinical trials, how to participate, and where to find information. The next generation of breakthroughs depends on it!”

Anastasia Albanese O'Neill, Ph.D., ARNP, CDCES

AVP, Community Screening and Clinical Trial Education

Clinical trials FAQs

A clinical trial is a research study involving human volunteers that tries to answer a specific health question. Clinical trials closely monitor people’s progress as they take part in the study of an investigational drug, device, or method of treatment that has not been approved by the FDA for that specific indication. Carefully conducted clinical trials are the gold standard to find treatments that work. Whether it’s an everyday, over-the-counter treatment, or the latest and greatest medical device, it went through the rigorous testing process of a clinical trial. 

  • You may get access to new treatments and technologies not available to the public. You may also have access to top diabetes clinics and researchers while enrolled in the clinical trial.
  • But one thing is certain: you will feel empowered knowing that your contribution to clinical research will help advance medical treatments and technologies for future generations!

There are many clinical trials that a person with long-standing T1D diagnosis can enroll in. Go to the Breakthrough T1D Clinical Trials Connection, and enter where you live, the distance you can travel, and other attributes to be matched with clinical trials that you may be eligible for. You can even get up-to-date information on new trials when you enter your email address. Find your local Breakthrough T1D CTEV to discuss clinical trials in your area or virtual trials

All clinical trials have guidelines, called eligibility criteria, about who can participate. The criteria are based on such factors as age, sex, stage of disease, previous treatment history, and other medical history. These criteria help to reduce the risk to an individual and variation within the study, and to ensure that the researchers will be able to answer the questions they plan to study. Therefore, not everyone who applies for a clinical trial will be able to participate. 

In clinical trials, experimental drugs are often compared with placebos (a treatment with no therapeutic value) to evaluate the treatment’s effectiveness. 

Breakthrough T1D  has an easy-to-use tool called the Clinical Trials Connection, which asks users simple questions—about where they live, the distance they can travel, and other characteristics—to match them with trials for which they are eligible. Currently, there are more than 300 clinical trials for people living with T1D and T1D-related complications underway.

Currently, there are more than 300 clinical trials for people living with T1D and T1D-related complications under way. 

Unfortunately, no. Many clinical trials are delayed or fail because doctors cannot find enough people to take part. 

Currently recruiting research in type 1 diabetes 

Currently Recruiting Disease-Modifying Therapy Clinical Trials
Learn about currently recruiting clinical trials for disease-modifying therapies.
Currently Recruiting Cell Therapy Clinical Trials
Learn about currently recruiting clinical trials for cell therapies.
Currently Recruiting Virtual Clinical Trials
Learn about currently recruiting clinical trials that are being conducted virtually.

Meet clinical trial participants

Hear from real people who participate in type 1 diabetes clinical trials:

Marjorie, a type 1 diabetes clinical trial patient

Marjorie

“Clinical trials are the only way to get to a cure. The more folks that participate, the more data we have to improve and optimize treatment options.”

Elijah, a type 1 diabetes clinical trial patient

Elijah

“Participating in clinical trials has given me valuable insights into the latest T1D research and provided me with a strong sense of community.”

Rob, a type 1 diabetes clinical trial participant

Rob

“To reach our dream of finding cures for type 1 diabetes, we need to step forward to test new T1D treatments and technologies.”

Clinical Trial Education Volunteers

Your key to participation!

Our national team of Clinical Trial Education Volunteers (CTEVs) are highly trained to answer any questions you may have or introduce you to the clinical trial team near you.

Jude Restis: jrestis@yahoo.com

Laura Tremblay: ldtremblay71@gmail.com

Bithika Thompson: Thompson.Bithika@mayo.edu

Northern California:
Kim Fisher: kimfisherschwab@gmail.com

Arshia Baig: cpa.baig@gmail.com

Joe Carlino: carlino1@earthlink.net

Vanessa Larco: vanessa.larco@gmail.com

Kirin Jamison: kirinj@gmail.com


Southern California:
Jeannette Hacker-Stratton: jstratton@coh.org

Allison Orechwa: allieot1d@gmail.com

Meredith Coors: meredithcoors@gmail.com

Marjorie Lazarre: majorie.lazarre@ynhh.org

Atlanta area:
Kim Kukler: kimkukler@gmail.com

Other areas:
Holly Hailey: hollyhailey@comcast.net

Donny Harris: donnyharris1917@gmail.com

Tampa area:
Craig Bobik: cbobik32@gmail.com

Orlando and Jacksonville areas:
Anna Casu: anna.casu@adventhealth.com

Palm Beach:
Steve Fried: sfried1017@gmail.com

Mike Patipa: mpatipa@comcast.net

Jamie Felton: jamifelt@iu.edu

Julie Coffey: julie-coffey@mchsi.com

Karissa Thompson: karissathompson1@gmail.com

Kelly Hoenig: kellyhoenig@gmail.com

Emily Rapp: emilybrapp@gmail.com

Jamie Felton: jamifelt@iu.edu

Amanda Gilchrist: Amandajgilchrist@gmail.com

Kristin Neff: kristin.neff@gmail.com

Amanda Gilchrist: Amandajgilchrist@gmail.com

Kristin Neff: kristin.neff@gmail.com

Colleen Buggs-Saxton: cbuggs@med.wayne.edu

Mike Kay: kaymichael4@gmail.com

Jen Miner: jaminer1@yahoo.com

Meezan Hamzavi: meezan3304@gmail.com

Emily Rapp: emilybrapp@gmail.com

Julie Geddes: juliebgeddes@gmail.com

Karissa Thompson: karissathompson1@gmail.com

Kelly Hoenig: kellyhoenig@gmail.com

Julie Coffey: julie-coffey@mchsi.com

Laura Brigham: Lbrigham52@gmail.com

Bithika Thompson: Thompson.Bithika@mayo.edu

Amanda Gilchrist: Amandajgilchrist@gmail.com

Kristin Neff: kristin.neff@gmail.com

Sumita Singh: singhsum@yahoo.com

Bithika Thompson: Thompson.Bithika@mayo.edu

Andrea Cawein: andicawein@gmail.com

Alecia Wesner: aleciawesner@gmail.com

Natasha Bolick: ngbolick@gmail.com

Ashley Hack: ashley.hack@gmail.com

Jen Miner (Northern Ohio): jaminer1@yahoo.com

Jude Restis: jrestis@yahoo.com

Laura Tremblay: ldtremblay71@gmail.com

Western and Central Pennsylvania:

Gina Leckie (Pittsburgh): rleckieT1Dphd@gmail.com

Jennifer Lieb (Harrisburg): jenniferalieb@gmail.com

Amanda Gilchrist: Amandajgilchrist@gmail.com

Kristin Neff: kristin.neff@gmail.com

Chattanooga:
Priyanka Kalpande: priyanka.clinicaldata@gmail.com

Memphis:
Alana Altomare: altomarealana@gmail.com

Other areas:
Dongsoo Lee: dongsooleet1d@gmail.com

San Antonio:
Pam Banks: pambanks2004@gmail.com

Dallas/North Texas:
Mary Beth Cox: marybethcoxmd@gmail.com

Other areas:
Bonnie McCann-Crosby: BMMcCann@texaschildrens.org

Meredith Coors: meredithcoors@gmail.com

Amanda Gilchrist: Amandajgilchrist@gmail.com

Kristin Neff: kristin.neff@gmail.com

Jude Restis: jrestis@yahoo.com

Laura Tremblay: ldtremblay71@gmail.com

Meredith Coors: meredithcoors@gmail.com

Sponsors

These resources are made possible in part through the support of:

Genetech Logo
Lilly Logo
Medtronic Logo
Sanofi Logo
Vertex Logo